Thermo Fisher Scientific Inc. (TMO) has a MoatMap StockRank of 50/100 based on Quality (58/100), Value (36/100), and Momentum (42/100) factor scores. The current signal is HOLD. Thermo Fisher Scientific is a high-quality company with strong moats (Q: 47), but it is a widely recognized and well-priced business. It does not present an asymmetric opportunity driven by an *unpriced* macro inflection point as required by the Druckenmiller lens, with its low valuation score (V: 29) indicating it is not trading at a reasonable price.
Thermo Fisher Scientific Inc. is the world leader in serving science, providing analytical instruments, laboratory equipment, reagents, consumables, and services for research, clinical diagnostics, and industrial applications. Its extensive product portfolio, integrated solutions, and high switching costs create a significant competitive moat. The company maintains a market-leading position across diverse scientific disciplines and geographies, making it an essential partner for global R&D and healthcare advancement.
| Price | $487.22 |
| Market Cap | $166.6B |
| P/E (TTM) | 24.63 |
| P/E (Forward) | 16.42 |
| Price/Book | 3.16 |
| Return on Equity | 13.5% |
| Return on Invested Capital | 9.2% |
| Debt/Equity | 82.90 |
| Gross Margin | 40.9% |
| Operating Margin | 17.9% |
| Revenue Growth | 6.2% |
| Dividend Yield | 0.4% |
| Free Cash Flow | $5.5B |
Thermo Fisher Scientific Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).